Results for "oruka therapeutics".

Oruka Therapeutics, Inc. (ORKA) Discusses Interim Results From EVERLAST-A Study of ORKA-001 in Moderate to Severe Plaque Psoriasis - Slideshow

2026-04-29. The following slide deck was published by Oruka Therapeutics, Inc.…

Oruka Therapeutics prices $700M stock offering at $72.50/share